Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LEGN | APLS | APGE | ||
| Company | Legend Biotech Corp ADR | Apellis Pharmaceuticals Inc | Apogee Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 28.01 | 41.03 | 84.06 | ||
| High | 28.59 | 41.05 | 86.32 | ||
| Low | 27.61 | 41.03 | 84.06 | ||
| Latest | 27.95 | 41.03 | 86.90 | ||
| Change | -0.17 | unch | +3.87 | ||
| % Change | -0.60% | +0.01% | +4.66% | ||
| Volume | 256,577 | 1,266,217 | 3,021 | ||
| 20-Day Average Volume | 2,758,794 | 3,657,969 | 586,171 | ||
| Previous Close | 28.12 | 41.03 | 83.03 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.58 | 40.95 | 86.35 | ||
| 20-Day Raw Stochastic | 83.48% | 69.44% | 39.24% | ||
| 20-Day Relative Strength | 69.91 | 82.00 | 55.72 | ||
| Weighted Alpha | +6.88 | +25.64 | +100.47 | ||
| Today's Opinion | 40% Buy | 100% Buy | 80% Buy | ||
| Previous Opinion | 40% Buy | 100% Buy | 80% Buy | ||
| Last Month's Opinion | 80% Sell | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.91% since 05/04/26 | +0.15% since 05/04/26 | +3.32% since 05/04/26 | ||
| Low | 26.44 on 05/05/26 | 40.93 on 05/05/26 | 80.83 on 05/07/26 | ||
| High | 30.41 on 05/05/26 | 41.14 on 05/06/26 | 86.32 on 05/11/26 | ||
| 1-Month | |||||
| %Chg | +56.00% since 04/10/26 | +0.59% since 04/10/26 | +0.06% since 04/10/26 | ||
| Low | 17.64 on 04/13/26 | 40.70 on 04/13/26 | 80.52 on 05/04/26 | ||
| High | 30.41 on 05/05/26 | 41.14 on 05/06/26 | 95.32 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | +52.80% since 02/11/26 | +83.91% since 02/11/26 | +31.17% since 02/11/26 | ||
| Low | 16.70 on 03/30/26 | 16.83 on 03/30/26 | 65.22 on 03/20/26 | ||
| High | 30.41 on 05/05/26 | 41.14 on 05/06/26 | 95.32 on 04/17/26 | ||
| 6-Month | |||||
| %Chg | -11.55% since 11/11/25 | +110.30% since 11/11/25 | +37.13% since 11/11/25 | ||
| Low | 16.24 on 02/04/26 | 16.83 on 03/30/26 | 60.35 on 02/09/26 | ||
| High | 33.50 on 11/12/25 | 41.14 on 05/06/26 | 95.32 on 04/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,200,963 | 5,252,701 | 5,135,655 | ||
| Shares Outstanding, K | 184,956 | 128,021 | 61,853 | ||
| Annual Sales | 1,028,900,000 | 1,003,780,000 | 0 | ||
| Annual Net Income | -296,800,000 | 22,390,000 | -255,840,000 | ||
| Last Quarter Sales | 306,460,000 | 199,910,000 | 0 | ||
| Last Quarter Net Income | -30,810,000 | -58,950,000 | -69,390,000 | ||
| 60-Month Beta | 0.29 | -0.24 | 0.69 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 03/10/26 | -0.47 on 02/24/26 | -1.03 on 03/02/26 | ||
| Earnings Date | 05/12/26 | 07/30/26 | 05/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 40.21 | 0.00 | ||